BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Márquez M, Fernández-Gutiérrez C, Montes-de-Oca M, Blanco MJ, Brun F, Rodríguez-Ramos C, Girón-González JA. Chronic antigenic stimuli as a possible explanation for the immunodepression caused by liver cirrhosis. Clin Exp Immunol. 2009;158:219-229. [PMID: 19737142 DOI: 10.1111/j.1365-2249.2009.04005.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 46] [Article Influence: 2.9] [Reference Citation Analysis]
Number Citing Articles
1 Dalla-Pozza P, Hentzien M, Allavena C, Doe de Maindreville A, Bouiller K, Valantin MA, Lafont E, Zaegel-Faucher O, Cheret A, Martin-Blondel G, Cotte L, Bani-Sadr F; Dat’AIDS study group. Progressive multifocal leukoencephalopathy in patients with immunovirological control and at least 6 months of combination antiretroviral therapy. AIDS 2022;36:539-49. [PMID: 34873087 DOI: 10.1097/QAD.0000000000003145] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Zuluaga P, Teniente-Serra A, Fuster D, Quirant-Sánchez B, Hernandez-Rubio A, Martínez-Cáceres E, Muga R. Increased Natural Killer Cells Are Associated with Alcohol Liver Fibrosis and with T Cell and Cytotoxic Subpopulations Change. J Clin Med 2022;11:305. [PMID: 35054000 DOI: 10.3390/jcm11020305] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
3 Lauar ID, Faria LC, Romanelli RMC, Clemente WT. Latent tuberculosis: Risk factors, screening and treatment in liver transplantation recipients from an endemic area. World J Transplant 2021; 11(12): 512-522 [DOI: 10.5500/wjt.v11.i12.512] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
4 Li Z, Jiang J. The NLRP3 inflammasome mediates liver failure by activating procaspase-1 and pro-IL-1 β and regulating downstream CD40-CD40L signaling. J Int Med Res 2021;49:3000605211036845. [PMID: 34551597 DOI: 10.1177/03000605211036845] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Lee DU, Fan GH, Hastie DJ, Prakasam VN, Addonizio EA, Ahern RR, Seog KJ, Karagozian R. The Clinical Impact of Cirrhosis on the Hospital Outcomes of Patients Admitted With Influenza Infection: Propensity Score Matched Analysis of 2011-2017 US Hospital Data. J Clin Exp Hepatol 2021;11:531-43. [PMID: 34511813 DOI: 10.1016/j.jceh.2021.01.005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
6 Okamoto T, Fukuda K. Cryptococcus: A Rare Cause of Parotid Abscess in Liver Cirrhosis. Case Reports Hepatol 2020;2020:8849448. [PMID: 33282423 DOI: 10.1155/2020/8849448] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
7 Hentzien M, Guihot A, de Maindreville D, Tabary T, Brodard V, Vieillard V, Adle-Biassette H, Bani-Sadr F. Progressive multifocal leukoencephalopathy despite immune recovery in a HIV/HCV co-infected patient. J Neurovirol 2020;26:607-10. [PMID: 32458280 DOI: 10.1007/s13365-020-00848-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
8 Tsai HC, Hsu CF, Huang CC, Huang SF, Li TH, Yang YY, Lin MW, Lee TY, Liu CW, Huang YH, Hou MC, Lin HC. Propranolol Suppresses the T-Helper Cell Depletion-Related Immune Dysfunction in Cirrhotic Mice. Cells 2020;9:E604. [PMID: 32138352 DOI: 10.3390/cells9030604] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
9 Rigopoulou EI, Gershwin ME, Bogdanos DP. Immune Responses to Bacterial Infections. Liver Immunology 2020. [DOI: 10.1007/978-3-030-51709-0_12] [Reference Citation Analysis]
10 So-Armah K, Freiberg M, Cheng D, Lim JK, Gnatienko N, Patts G, Doyle M, Fuster D, Lioznov D, Krupitsky E, Samet J. Liver fibrosis and accelerated immune dysfunction (immunosenescence) among HIV-infected Russians with heavy alcohol consumption - an observational cross-sectional study. BMC Gastroenterol 2019;20:1. [PMID: 31892306 DOI: 10.1186/s12876-019-1136-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
11 Di Dato F, Nunziata F, Rosa M, Iorio R, Spagnuolo MI. Tubercular hemoptysis in a young liver transplanted patient: Case report. Medicine (Baltimore) 2019;98:e16761. [PMID: 31415374 DOI: 10.1097/MD.0000000000016761] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
12 Wu X, Shi Y, Zhou J, Sun Y, Piao H, Jiang W, Ma A, Chen Y, Xu M, Xie W, Cheng J, Xie S, Shang J, Cheng J, Xie Q, Ding H, Zhang X, Bai L, Zhang M, Wang B, Chen S, Ma H, Ou X, Jia J, You H. Combination of entecavir with thymosin alpha-1 in HBV-related compensated cirrhosis: a prospective multicenter randomized open-label study. Expert Opin Biol Ther 2018;18:61-9. [PMID: 30063860 DOI: 10.1080/14712598.2018.1451511] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
13 Billa O, Chalouni M, Salmon D, Poizot-Martin I, Gilbert C, Katlama C, Neau D, Chas J, Morlat P, Lacombe K, Naqvi A, Barange K, Gervais A, Bouchaud O, Rosenthal E, Lascoux-Combe C, Garipuy D, Alric L, Dominguez S, Vittecoq D, Goujard C, Duvivier C, Aumaitre H, Miailhes P, Zucman D, Simon A, Lazaro E, Raffi F, Esterle L, Wittkop L, Bani-Sadr F; ANRS CO13 HEPAVIH Study Group. Factors associated with non-AIDS-defining cancers and non HCV-liver related cancers in HIV/HCV-coinfected patients- ANRS-CO13 HEPAVIH cohort. PLoS One 2018;13:e0208657. [PMID: 30562358 DOI: 10.1371/journal.pone.0208657] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
14 Qiu J, Liu S, Wang Q. Treatment of tuberculosis infection complicated with liver transplant. Infection International 2018;7:81-7. [DOI: 10.2478/ii-2018-0025] [Reference Citation Analysis]
15 Noceti O, Pouché L, Esperón P, Lens D, Vital M, Touriño C, Gerona S, Woillard J, Marquet P. Activity of the Calcineurin Pathway in Patients on the Liver Transplantation Waiting List: Factors of Variability and Response to Tacrolimus Inhibition. Clinical Chemistry 2017;63:1734-44. [DOI: 10.1373/clinchem.2017.272534] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
16 Kogiso T, Egawa H, Teramukai S, Taniai M, Hashimoto E, Tokushige K, Sakisaka S, Sakabayashi S, Yamamoto M, Umeshita K, Uemoto S. Risk factors for recurrence of primary biliary cholangitis after liver transplantation in female patients: A Japanese multicenter retrospective study. Hepatol Commun 2017;1:394-405. [PMID: 29404468 DOI: 10.1002/hep4.1037] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
17 Noor MT, Manoria P. Immune Dysfunction in Cirrhosis. J Clin Transl Hepatol. 2017;5:50-58. [PMID: 28507927 DOI: 10.14218/jcth.2016.00056] [Cited by in Crossref: 20] [Cited by in F6Publishing: 43] [Article Influence: 3.3] [Reference Citation Analysis]
18 Papp M, Tornai T, Vitalis Z, Tornai I, Tornai D, Dinya T, Sumegi A, Antal-Szalmas P. Presepsin teardown - pitfalls of biomarkers in the diagnosis and prognosis of bacterial infection in cirrhosis. World J Gastroenterol 2016; 22(41): 9172-9185 [PMID: 27895404 DOI: 10.3748/wjg.v22.i41.9172] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
19 Burke Schinkel SC, Carrasco-Medina L, Cooper CL, Crawley AM. Generalized Liver- and Blood-Derived CD8+ T-Cell Impairment in Response to Cytokines in Chronic Hepatitis C Virus Infection. PLoS One 2016;11:e0157055. [PMID: 27315061 DOI: 10.1371/journal.pone.0157055] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
20 Márquez M, Fernández Gutiérrez del Álamo C, Girón-González JA. Gut epithelial barrier dysfunction in human immunodeficiency virus-hepatitis C virus coinfected patients: Influence on innate and acquired immunity. World J Gastroenterol 2016; 22(4): 1433-1448 [PMID: 26819512 DOI: 10.3748/wjg.v22.i4.1433] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
21 Márquez M, Romero-Cores P, Montes-Oca M, Martín-Aspas A, Soto-Cárdenas MJ, Guerrero F, Fernández-Gutiérrez C, Girón-González JA. Immune activation response in chronic HIV-infected patients: influence of Hepatitis C virus coinfection. PLoS One. 2015;10:e0119568. [PMID: 25775475 DOI: 10.1371/journal.pone.0119568] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 4.0] [Reference Citation Analysis]
22 Støy S, Dige A, Sandahl TD, Laursen TL, Buus C, Hokland M, Vilstrup H. Cytotoxic T lymphocytes and natural killer cells display impaired cytotoxic functions and reduced activation in patients with alcoholic hepatitis. Am J Physiol Gastrointest Liver Physiol 2015;308:G269-76. [PMID: 25501547 DOI: 10.1152/ajpgi.00200.2014] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
23 Xu D, Zhao M, Song Y, Song J, Huang Y, Wang J. Novel insights in preventing Gram-negative bacterial infection in cirrhotic patients: review on the effects of GM-CSF in maintaining homeostasis of the immune system. Hepatol Int 2015;9:28-34. [DOI: 10.1007/s12072-014-9588-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
24 Sipeki N, Antal-Szalmas P, Lakatos PL, Papp M. Immune dysfunction in cirrhosis. World J Gastroenterol 2014; 20(10): 2564-2577 [PMID: 24627592 DOI: 10.3748/wjg.v20.i10.2564] [Cited by in CrossRef: 111] [Cited by in F6Publishing: 112] [Article Influence: 12.3] [Reference Citation Analysis]
25 Bruns T, Zimmermann HW, Stallmach A. Risk factors and outcome of bacterial infections in cirrhosis. World J Gastroenterol 2014; 20(10): 2542-2554 [PMID: 24627590 DOI: 10.3748/wjg.v20.i10.2542] [Cited by in CrossRef: 85] [Cited by in F6Publishing: 88] [Article Influence: 9.4] [Reference Citation Analysis]
26 Pieri G, Agarwal B, Burroughs AK. C-reactive protein and bacterial infection in cirrhosis. Ann Gastroenterol 2014;27:113-20. [PMID: 24733601] [Reference Citation Analysis]
27 Lario M, Muñoz L, Ubeda M, Borrero MJ, Martínez J, Monserrat J, Díaz D, Alvarez-Mon M, Albillos A. Defective thymopoiesis and poor peripheral homeostatic replenishment of T-helper cells cause T-cell lymphopenia in cirrhosis. J Hepatol 2013;59:723-30. [PMID: 23742913 DOI: 10.1016/j.jhep.2013.05.042] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 3.5] [Reference Citation Analysis]
28 Zhang Q, Yin J, Zhang Y, Deng Y, Ji X, Du Y, Pu R, Han Y, Zhao J, Han X. HLA-DP polymorphisms affect the outcomes of chronic hepatitis B virus infections, possibly through interacting with viral mutations. J Virol. 2013;87:12176-12186. [PMID: 24006435 DOI: 10.1128/jvi.02073-13] [Cited by in Crossref: 44] [Cited by in F6Publishing: 48] [Article Influence: 4.4] [Reference Citation Analysis]
29 Ko FY, Tsai SJ, Yang AC, Zhou Y, Xu LM. Association of CD8 T cells with depression and anxiety in patients with liver cirrhosis. Int J Psychiatry Med 2013;45:15-29. [PMID: 23805601 DOI: 10.2190/PM.45.1.b] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
30 Tarallo PA, Smolowitz J, Carriero D, Tarallo J, Siegel A, Jia H, Emond JC. Prevalence of high-risk human papilloma virus among women with hepatitis C virus before liver transplantation. Transpl Infect Dis 2013;15:400-4. [PMID: 23647866 DOI: 10.1111/tid.12086] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
31 Zimmermann HW, Reuken PA, Koch A, Bartneck M, Adams DH, Trautwein C, Stallmach A, Tacke F, Bruns T. Soluble urokinase plasminogen activator receptor is compartmentally regulated in decompensated cirrhosis and indicates immune activation and short-term mortality. J Intern Med. 2013;274:86-100. [PMID: 23432143 DOI: 10.1111/joim.12054] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 3.6] [Reference Citation Analysis]
32 Peter J, Frey O, Stallmach A, Bruns T. Attenuated antigen-specific T cell responses in cirrhosis are accompanied by elevated serum interleukin-10 levels and down-regulation of HLA-DR on monocytes. BMC Gastroenterol. 2013;13:37. [PMID: 23446058 DOI: 10.1186/1471-230x-13-37] [Cited by in Crossref: 23] [Cited by in F6Publishing: 27] [Article Influence: 2.3] [Reference Citation Analysis]
33 Mitterhofer AP, Tinti F, Umbro I, Pietropaolo V, Fiacco F, Bellizzi A, Anzivino E, Ginanni Corradini S, Poli L, Rossi M. Polyomavirus BK infection before liver transplantation in patients with chronic kidney disease. Transplant Proc. 2012;44:1934-1937. [PMID: 22974876 DOI: 10.1016/j.transproceed.2012.06.052] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
34 Ilan Y. Leaky gut and the liver: A role for bacterial translocation in nonalcoholic steatohepatitis. World J Gastroenterol 2012; 18(21): 2609-2618 [PMID: 22690069 DOI: 10.3748/wjg.v18.i21.2609] [Cited by in CrossRef: 131] [Cited by in F6Publishing: 135] [Article Influence: 11.9] [Reference Citation Analysis]
35 Papp M, Vitalis Z, Altorjay I, Tornai I, Udvardy M, Harsfalvi J, Vida A, Kappelmayer J, Lakatos PL, Antal-Szalmas P. Acute phase proteins in the diagnosis and prediction of cirrhosis associated bacterial infections. Liver Int 2012;32:603-11. [PMID: 22145664 DOI: 10.1111/j.1478-3231.2011.02689.x] [Cited by in Crossref: 61] [Cited by in F6Publishing: 60] [Article Influence: 5.5] [Reference Citation Analysis]
36 Galioto A, Morando F, Rosi S, Schipilliti M, Fasolato S, Magrin M, Frigo AC, Adami F, Cavallin M, Zanus G, Plebani M, Romano A, Sticca A, Cillo U, Gatta A, Angeli P. Monoclonal gammopathy after liver transplantation: a risk factor for long-term medical complications other than malignancies: MGUS and liver transplantation. Transplant International 2012;25:25-33. [DOI: 10.1111/j.1432-2277.2011.01362.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
37 Mitterhofer AP, Tinti F, Mordenti M, Pietropaolo V, Colosimo M, Ginanni Corradini S, Chiarini F, Rossi M, Ferretti G, Brunini F. Polyomavirus BK replication in liver transplant candidates with normal renal function. Transplant Proc. 2011;43:1142-1144. [PMID: 21620073 DOI: 10.1016/j.transproceed.2011.02.048] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
38 Montes-de-Oca M, Blanco MJ, Marquez M, Soto MJ, Fernandez-Gutiérrez C, Rodriguez-Ramos C, Giron-Gonzalez JA. Haemodynamic derangement in human immunodeficiency virus-infected patients with hepatitis C virus-related cirrhosis: the role of bacterial translocation. Liver Int 2011;31:850-8. [PMID: 21645216 DOI: 10.1111/j.1478-3231.2011.02505.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
39 Barbero-Becerra VJ, Gutiérrez-Ruiz MC, Maldonado-Bernal C, Téllez-Avila FI, Alfaro-Lara R, Vargas-Vorácková F. Vigorous, but differential mononuclear cell response of cirrhotic patients to bacterial ligands. World J Gastroenterol 2011; 17(10): 1317-1325 [PMID: 21455331 DOI: 10.3748/wjg.v17.i10.1317] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
40 Piano S, Morando F, Angeli P. Spontaneous Bacterial Peritonitis in Patients with Cirrhosis and Ascites. Annual Update in Intensive Care and Emergency Medicine 2011 2011. [DOI: 10.1007/978-3-642-18081-1_51] [Reference Citation Analysis]
41 Macnaughtan J, Stadlbauer V, Mookerjee R, Jalan R. SIRS, Bacterial Infections, and Alterations of the Immune System. Chronic Liver Failure 2011. [DOI: 10.1007/978-1-60761-866-9_11] [Reference Citation Analysis]
42 Yehia BR, Blumberg EA. Mycobacterium tuberculosis infection in liver transplantation. Liver Transpl 2010;16:1129-35. [PMID: 20879011 DOI: 10.1002/lt.22133] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 3.1] [Reference Citation Analysis]
43 Yang MC, Chang CP, Lei HY. Induction of liver fibrosis in a murine hepatoma model by thioacetamide is associated with enhanced tumor growth and suppressed antitumor immunity. Lab Invest 2010;90:1782-93. [PMID: 20680008 DOI: 10.1038/labinvest.2010.139] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
44 Grandini E, Cannoletta F, Scuteri A, Fortini C, Loggi E, Cursaro C, Riili A, Di Donato R, Gramenzi A, Bernardi M, Andreone P. Immunological modifications during treatment with thymosin α1 plus antiviral therapy in chronic hepatitis C: Tα1 and CHC. Annals of the New York Academy of Sciences 2010;1194:147-52. [DOI: 10.1111/j.1749-6632.2010.05461.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
45 Focosi D, Bestagno M, Burrone O, Petrini M. CD57+ T lymphocytes and functional immune deficiency. J Leukoc Biol. 2010;87:107-116. [PMID: 19880576 DOI: 10.1189/jlb.0809566] [Cited by in Crossref: 166] [Cited by in F6Publishing: 176] [Article Influence: 11.9] [Reference Citation Analysis]